How blood-testing startups are pitching themselves after the Theranos scandal
Published: June 25, 2018 By EMMACOURT The Theranos saga created interest in upending the $54 billion, but ‘antiquated,’ blood-testing industry Startup Genalyte Inc. wants to revolutionize the way blood testing is done. If its vision pans out, the privately held...
Like Theranos, but it works”–health startup Genalyte proves its worth
Published: June 13, 2018 BY RINA RAPHAEL-Fast Company The transparent diagnostics company raised over $91 million in funding. Can it overcome the skepticism Theranos left in its wake? [Image: courtesy of Genalyte] Last month, I had my blood work requested, tested, and...
THERANOS DIDN’T NUKE THE DIAGNOSTICS BUSINESS
Published: March 15, 2018 Adam Rogers- WIRED IT TOOK TEN years to build the Maverick, a dorm-fridge-sized box that takes in a cartridge with a little bit of blood—more than a drop but, you know, not a pint, either—and spits out new knowledge. On the cartridge is a...
With Theranos in Tatters, Genalyte Keeps Blood Testing Relevant
FOX Business contributor Dr. Mike Varshavski on how San Diego-based company Genalyte is keeping blood testing relevant after the collapse of Theranos.
How to woo investors at #JPM18: Stick a needle in their arm
It’s Sunday evening in San Francisco, the night before the madness that is the annual J.P. Morgan Healthcare conference begins.